← Eichor
Study identifier: NCT05482269 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography

Condition: Pulmonary Embolism and Thrombosis · Deterioration, Clinical · Artificial Intelligence  ·  Sponsor: Shengjing Hospital

PhaseN/A
Planned participants2000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The investigators aim to build a predictive tool for Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography.

This description comes directly from the study's public registry record.

Talk to the study team

DONG JIA  ·  +86-18940252800  ·  jiadong0101@126.com

YIZHUO GAO  ·  +86-18940257523  ·  gaoyizhuo.sy@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shengjing HospitalShenyang, Liaoning, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05482269